|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date21 Apr 2025 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date10 Dec 2024 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date15 Nov 2024 |
100 Clinical Results associated with SUNGYI BIO. CO., LTD
0 Patents (Medical) associated with SUNGYI BIO. CO., LTD
100 Deals associated with SUNGYI BIO. CO., LTD
100 Translational Medicine associated with SUNGYI BIO. CO., LTD